52 related articles for article (PubMed ID: 16365133)
1. Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia.
Fabeck L; Ghafil D; Gerroudj M; Baillon R; Delincé P
J Bone Joint Surg Br; 2006 Jan; 88(1):116-8. PubMed ID: 16365133
[TBL] [Abstract][Full Text] [Related]
2. Guided Growth to Treat Anterolateral Tibial Bowing Associated with Congenital Pseudarthrosis of the Tibia.
Todderud JE; Carlson SW; Larson AN
J Pediatr Orthop; 2024 Jul; 44(6):e560-e565. PubMed ID: 38835290
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of tibial pseudarthrosis with constriction band syndrome in children.
Naik P; Shah H; Gupta P
J Pediatr Orthop B; 2022 Mar; 31(2):150-159. PubMed ID: 33764035
[TBL] [Abstract][Full Text] [Related]
4. Challenges with Fassier-Duval rod exchanges in congenital pseudarthrosis of the tibia: explant roadblock and solution.
McClure PK; Franzone JM; Herzenberg JE
J Pediatr Orthop B; 2022 Jan; 31(1):e95-e100. PubMed ID: 34380988
[TBL] [Abstract][Full Text] [Related]
5. Not just a fracture.
Van de Vijver M
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24501336
[No Abstract] [Full Text] [Related]
6. AN ADJUNCTIVE USE OF ASFOTASE ALFA AND ZOLEDRONIC ACID AFTER SPINAL SURGERY IN NEUROFIBROMATOSIS TYPE 1 RELATED DYSTROPHIC SCOLIOSIS.
Harindhanavudhi T; Takahashi T; Petryk A; Polly DW
AACE Clin Case Rep; 2020; 6(6):e305-e310. PubMed ID: 33244490
[TBL] [Abstract][Full Text] [Related]
7. Congenital pseudarthrosis of the tibia: Results of circular external fixation treatment with intramedullary rodding and periosteal grafting technique.
Kocaoğlu M; Eralp L; Bilen FE; Civan M
Acta Orthop Traumatol Turc; 2020 May; 54(3):245-254. PubMed ID: 32442122
[TBL] [Abstract][Full Text] [Related]
8. Congenital Pseudarthrosis of the Tibia: Results, at Skeletal Maturity, of the Charnley-Williams Procedure.
Singer D; Johnston CE
JB JS Open Access; 2019; 4(2):e0004. PubMed ID: 31334459
[TBL] [Abstract][Full Text] [Related]
9. The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.
Tahaei SE; Couasnay G; Ma Y; Paria N; Gu J; Lemoine BF; Wang X; Rios JJ; Elefteriou F
Bone; 2018 Jan; 106():103-111. PubMed ID: 29032173
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: A retrospective study with a minimum 2-year follow-up.
Hissnauer TN; Stiel N; Babin K; Rupprecht M; Hoffmann M; Rueger JM; Stuecker R; Spiro AS
J Mater Sci Mater Med; 2017 Apr; 28(4):60. PubMed ID: 28213747
[TBL] [Abstract][Full Text] [Related]
11. The use of recombinant morphogenic protein-2(rhBMP-2) in children undergoing revision surgery for persistent non-union.
Papanna MC; Saldanha KA; Kurian B; Fernandes JA; Jones S
Strategies Trauma Limb Reconstr; 2016 Apr; 11(1):53-8. PubMed ID: 26984411
[TBL] [Abstract][Full Text] [Related]
12. Computational modeling of bone fracture non-unions: four clinically relevant case studies.
Carlier A; Lammens J; Van Oosterwyck H; Geris L
In Silico Cell Tissue Sci; 2015; 2():1. PubMed ID: 26709368
[TBL] [Abstract][Full Text] [Related]
13. Ilizarov bone transport as a treatment of congenital pseudarthrosis of the tibia: a long-term follow-up study.
Vanderstappen J; Lammens J; Berger P; Laumen A
J Child Orthop; 2015 Aug; 9(4):319-24. PubMed ID: 26266468
[TBL] [Abstract][Full Text] [Related]
14. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
J Bone Miner Res; 2015 Jan; 30(1):55-63. PubMed ID: 25043591
[TBL] [Abstract][Full Text] [Related]
15. Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
de la Croix Ndong J; Makowski AJ; Uppuganti S; Vignaux G; Ono K; Perrien DS; Joubert S; Baglio SR; Granchi D; Stevenson DA; Rios JJ; Nyman JS; Elefteriou F
Nat Med; 2014 Aug; 20(8):904-10. PubMed ID: 24997609
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial.
Das SP; Ganesh S; Pradhan S; Singh D; Mohanty RN
Int Orthop; 2014 Sep; 38(9):1987-92. PubMed ID: 24827969
[TBL] [Abstract][Full Text] [Related]
17. Congenital pseudarthrosis of the tibia: the results of an evolving protocol of management.
Nicolaou N; Ghassemi A; Hill RA
J Child Orthop; 2013 Oct; 7(4):269-76. PubMed ID: 24432086
[TBL] [Abstract][Full Text] [Related]
18. Masquelet's procedure and bone morphogenetic protein in congenital pseudarthrosis of the tibia in children: a case series and meta-analysis.
Dohin B; Kohler R
J Child Orthop; 2012 Aug; 6(4):297-306. PubMed ID: 23904896
[TBL] [Abstract][Full Text] [Related]
19. Congenital pseudarthrosis of the tibia: Management and complications.
Shah H; Rousset M; Canavese F
Indian J Orthop; 2012 Nov; 46(6):616-26. PubMed ID: 23325962
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.
Birke O; Schindeler A; Ramachandran M; Cowell CT; Munns CF; Bellemore M; Little DG
J Child Orthop; 2010 Dec; 4(6):507-17. PubMed ID: 22132028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
